Gloria Van Rees

There is a growing scandal in China over vaccines that are alleged to be inefficient in combating disease. The company at the center of scandal is Changsheng Biotechnology. The number of vaccines potentially tainted can be seen in the figure below. It is too early to tell if this will be a scandal on par with the milk scandal nearly 10 years ago, but this should put pressure on Chinese pharmaceutical companies to prove the efficacy of their products. TDAP and Influenza releases have not been reported since November 2017 and January 2018 respectively.